A six-months, long acting, one-shot injectable formulation of Ivermectin as a complementary malaria vector control tool to target zoophagic Anopheles : laboratory and model-based proofs of concept.
S. H. Pooda, N. Moiroux, A. Porciani, A.-L. Courgeault, C. Roberge, G. Gaudriault, I. Sidibe, A. M. G. Belem, J.-B. Rayaisse, R. K. Dabire, K. Mouline
This paper demonstrates that a long-acting injectable ivermectin formulation reduces Anopheles mosquito populations, potentially decreasing malaria transmission.
bioRxiv · Apr 7, 2022 · PreprintPharmacology & Toxicology